Mettler-Toledo International Inc.
General ticker "MTD" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $25.8B (TTM average)
Mettler-Toledo International Inc. closely follows the US Stock Market performance with the rate: 75.9%.
Estimated limits based on current volatility of 1.8%: low 1236.32$, high 1282.54$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 17300 (0.0%) as of 2024
- US accounted for 36.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Cybersecurity threats, Supply chain disruptions, Pandemic risks, Labor/talent shortage/retention
- Current price 10.2% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1347.04$, 1825.22$]
- 2026-12-31 to 2027-12-31 estimated range: [1501.82$, 2003.60$]
Financial Metrics affecting the MTD estimates:
- Positive: with PPE of 32.9 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 27.78 > 18.38
- Positive: Inventory ratio change, % of 0.33 <= 0.80
- Negative: Shareholder equity ratio, % of -0.64 <= 19.40
- Positive: Return on assets ratio (scaled to [-100,100]) of 18.97 > 6.11
- Positive: -4.43 < Investing cash flow per share per price, % of -0.67
- Positive: 0.01 < Operating cash flow per share per price, % of 3.30
Short-term MTD quotes
Long-term MTD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3,788.31MM | $3,872.36MM | $4,026.40MM |
| Operating Expenses | $2,708.63MM | $2,745.31MM | $2,907.91MM |
| Operating Income | $1,079.68MM | $1,127.05MM | $1,118.49MM |
| Non-Operating Income | $-105.95MM | $-89.83MM | $-69.58MM |
| Interest Expense | $77.37MM | $74.63MM | $68.52MM |
| R&D Expense | $185.28MM | $189.36MM | $199.37MM |
| Income(Loss) | $973.73MM | $1,037.22MM | $1,048.91MM |
| Taxes | $184.95MM | $174.08MM | $179.72MM |
| Profit(Loss)* | $788.78MM | $863.14MM | $869.19MM |
| Stockholders Equity | $-149.94MM | $-126.89MM | $-23.64MM |
| Inventory | $385.87MM | $342.27MM | $387.23MM |
| Assets | $3,355.55MM | $3,240.00MM | $3,712.65MM |
| Operating Cash Flow | $965.87MM | $968.35MM | $955.77MM |
| Capital expenditure | $105.32MM | $103.90MM | $107.12MM |
| Investing Cash Flow | $-131.69MM | $-119.46MM | $-193.87MM |
| Financing Cash Flow | $-859.59MM | $-855.98MM | $-755.17MM |
| Earnings Per Share** | $36.10 | $40.67 | $42.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.